-
WHEN UTILITY DATA ARE SCARCE: METHODS AND ACCEPTABILITY IN NICE RARE DISEASE APPRAISALS
Aug 25, 2026, 15:54 PM -
STATISTICAL LESSONS FROM EARLY EU JOINT CLINICAL ASSESSMENTS AND IMPLICATIONS FOR RARE-DISEASE HTA ACROSS EU-25: THE ROLE OF EARLY AUTOMATION IN IDENTIFYING EVIDENCE GAPS
Aug 25, 2026, 15:54 PM -
EU JOINT CLINICAL ASSESSMENT OF TOVORAFENIB: METHODOLOGICAL LEARNINGS FOR FUTURE ORPHAN DOSSIERS
Aug 25, 2026, 15:54 PM -
RACING AGAINST RARITY: CAN EVIDENCE GATHERED BETWEEN ENTRY AND EXIT OF CONDITIONAL ACCESS AGREEMENTS RESOLVE UNCERTAINTY IN RARE DISEASES?
Aug 25, 2026, 15:54 PM -
BEYOND INCOME TIERS: AN ADAPTIVE VALUE-BASED PRICING FRAMEWORK TO RECONCILE ACCESS, EQUITY, AND INNOVATION FOR ON-PATENT MEDICINES IN LMICS
Aug 25, 2026, 15:54 PM -
FROM PRICE COMPRESSION TO LIFECYCLE VALUE MANAGEMENT: IMPLICATIONS OF CHINA'S 2026 DRUG PRICING REFORM
Aug 25, 2026, 15:54 PM -
US MOST FAVOURED NATION PRICING AND EU JOINT CLINICAL ASSESSMENT: A CEE-WEIGHTED PULSE CHECK ON LAUNCH STRATEGY, EVIDENCE GENERATION AND ACCESS RISK
Aug 25, 2026, 15:54 PM -
OPERATIONALISING JCA REQUIREMENTS FOR INDIRECT TREATMENT COMPARISONS: AN UPDATED SLR-BASED FRAMEWORK FOR IDENTIFYING TREATMENT EFFECT MODIFIERS AND PROGNOSTIC VARIABLES
Aug 25, 2026, 15:54 PM -
EXPLORING THE RELATIONSHIP BETWEEN SURROGATE ENDPOINTS AND CLINICAL OUTCOMES IN SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE (SSC-ILD): A SYSTEMATIC LITERATURE REVIEW
Aug 25, 2026, 15:54 PM -
A LIVING NETWORK META-ANALYSIS (NMA) FRAMEWORK INCORPORATING REAL-WORLD EVIDENCE (RWE) IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) USING THE ONCOSCOPE REAL-TIME AI-ASSISTED SYSTEMATIC LITERATURE REVIEW (REAL-SLR)
Aug 25, 2026, 15:54 PM -
MATCHING-ADJUSTED INDIRECT COMPARISON OF ETRANACOGENE DEZAPARVOVEC VERSUS MARSTACIMAB FOR THE TREATMENT OF SEVERE HEMOPHILIA B
Aug 25, 2026, 15:54 PM -
A HYBRID AI-ASSISTED SCREENING FRAMEWORK FOR SYSTEMATIC LITERATURE REVIEWS IN HER2-POSITIVE METASTATIC BREAST CANCER
Aug 25, 2026, 15:54 PM -
READY FOR PRIME TIME? EVALUATING LARGE LANGUAGE MODELS FOR AUTOMATED EXTRACTION OF COST-EFFECTIVENESS MODELS FROM HTA SUBMISSIONS
Aug 25, 2026, 15:54 PM -
MULTI-COUNTRY HEOR LANDSCAPE ASSESSMENT FOR MULTIPLE SCLEROSIS USING A MULTI-AGENT GENAI SYSTEM
Aug 25, 2026, 15:54 PM -
AI DELPHI: A FRAMEWORK FOR BENCHMARKING THE WRITING QUALITY OF LARGE LANGUAGE MODELS (LLMS) IN HEALTH ECONOMICS AND OUTCOMES RESEARCH (HEOR) SETTINGS, A CANADIAN PROOF-OF-CONCEPT
Aug 25, 2026, 15:54 PM -
QUANTIFYING UNMET CARE GAPS IN CHRONIC DISEASE AND CARDIOMETABOLIC MULTIMORBIDITY: THE CLINICAL, ECONOMIC AND MACROECONOMIC CASE FOR CLOSING THEM
Aug 25, 2026, 15:53 PM -
TERRITORIAL INEQUALITIES OF PRACTICING PHYSICIANS IN HUNGARY AND THE DACH COUNTRIES IN 2024: A GINI AND THEIL INDEX-BASED ANALYSIS
Aug 25, 2026, 15:53 PM -
DISAGGREGATING SOCIAL DETERMINANTS OF HEALTH TO PREDICT COLORECTAL CANCER SCREENING: A TRACT-LEVEL DOMINANCE ANALYSIS
Aug 25, 2026, 15:53 PM -
JOB LOSS AND CARDIOVASCULAR HEALTH: A LARGE-SCALE ANALYSIS ON THE IMPACT OF UNEMPLOYMENT ON MAJOR ADVERSE CARDIOVASCULAR EVENTS AND ALL-CAUSE MORTALITY
Aug 25, 2026, 15:53 PM -
GREENHOUSE GAS EMISSIONS AVOIDED THROUGH HPV VACCINATION IN CERVICAL CANCER AND CIN3 CARE PATHWAYS
Aug 25, 2026, 15:53 PM
